Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmala Foods Plc Regulatory News (DISH)

Share Price Information for Amala Foods Plc (DISH)

Share Price is delayed by 15 minutes
Get Live Data
0.0875    0.00 (0.00%)
Bid:
0.075
Ask:
0.10
Spread: 0.025 (33.333%)
Market Cap: £391.40k
DISH Live PriceLast checked at - London Stock Exchange

Intraday Amala Foods Plc Share Chart

Corporate Update

19 Apr 2023 07:00

RNS Number : 7225W
Amala Foods PLC
19 April 2023
 

 

Amala Foods Plc

("Amala" or the "Company")

 

 

Corporate Update

 

Amala Foods Plc (LON: DISH), a shell company, is pleased to provide a Corporate Update.

The Directors of the Company are pleased to confirm that the shares of the Company have been re-admitted to trading on the Standard Segment to the Main Market.

Further to the update of 17 March 2023, the Company has received confirmation prior to the suspension being lifted that the Company is "grandfathered" under the regime change so that, provided a reverse takeover is subject to eligibility and prospectus review and approval prior to 1 December 2023, that such reverse takeover can complete with a market capitalisation for the enlarged share capital of the Company of less than £30,000,000 (thirty million pounds).

As detailed in the previous corporate update, the Company has retained capital to undertake a reverse takeover and has ensured steps are taken to reduce working capital expenditures at this time including the Directors having agreed not to accrue nor receive any remuneration until a reverse takeover.

The Company has also added Ms Celia Li to the Directors with her expertise and experience with overseas investments and investors.

The Directors are currently exploring a number of reverse takeover opportunities and hope to produce a shortlist in the coming weeks. The Directors are targeting concluding heads of terms of a preferred target by the late Summer which will trigger a suspension of the shares in accordance with the Listing Rules.

Whilst there can be no assurances that a reverse takeover target will be identified, nor that a transaction can be concluded by 1 December 2023 so that eligibility and prospectus review can be completed by the FCA, the Directors are working hard to achieve these goals for the benefit for the shareholders and other stakeholders in the Company.

The Directors look forward to providing a further update in due course.

Furthermore, the Company has issued 23,299,314 shares at a price of £0.00344 per share to a creditor to reduce outstanding liabilities by £80,149.64. 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

 

Enquiries:

 

Jonathan Morley-Kirk, Non-Executive Chairman

jmk@bluebirdmv.com  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUKSVROOUSARR
Date   Source Headline
10th Jan 20227:00 amRNSAGM Results
20th Dec 20217:00 amRNSNotice of AGM
17th Dec 20217:00 amRNSTR-1 Notification of Major Holdings
8th Dec 20217:00 amRNSIssue of Equity
6th Dec 20212:06 pmRNSSecond Price Monitoring Extn
6th Dec 20212:00 pmRNSPrice Monitoring Extension
3rd Dec 20217:44 amRNSFurther re: Annual Financial Report
2nd Dec 20217:30 amRNSAnnual Financial Report 2021
9th Nov 20217:00 amRNSStatement re Audit Process and Operational Update
30th Sep 20217:00 amRNS2021 Annual Financial Report Publication Update
22nd Sep 20217:00 amRNSNew Company Website
9th Aug 20217:00 amRNSBusiness Update
23rd Jun 20217:00 amRNSOperational Update
2nd Jun 20217:00 amRNSOperational Update
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20212:01 pmRNSPrice Monitoring Extension
22nd Mar 20217:00 amRNSResult of General Meeting
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
25th Feb 20217:00 amRNSNotice of GM
16th Feb 20212:06 pmRNSSecond Price Monitoring Extn
16th Feb 20212:01 pmRNSPrice Monitoring Extension
3rd Feb 202111:05 amRNSSecond Price Monitoring Extn
3rd Feb 202111:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSOperational Update
29th Jan 20217:23 amRNSFinancial Report for the Half-Year to 30 Sept 2020
27th Jan 202111:05 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
8th Jan 20214:42 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSAGM Results and Business Update
7th Dec 20202:06 pmRNSSecond Price Monitoring Extn
7th Dec 20202:00 pmRNSPrice Monitoring Extension
4th Dec 20209:05 amRNSSecond Price Monitoring Extn
4th Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20202:06 pmRNSSecond Price Monitoring Extn
3rd Dec 20202:01 pmRNSPrice Monitoring Extension
3rd Dec 202011:06 amRNSSecond Price Monitoring Extn
3rd Dec 202011:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSBusiness Update
12th Oct 20207:00 amRNSStrategy and Operational Update
2nd Oct 20207:00 amRNSOperational Update
30th Sep 20207:00 amRNSAnnual Financial Report
28th Sep 20207:00 amRNSFurther re Funding Update
24th Sep 20207:00 amRNSFunding Update
21st Sep 20202:06 pmRNSSecond Price Monitoring Extn
21st Sep 20202:00 pmRNSPrice Monitoring Extension
20th Aug 20207:00 amRNSTechnology Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.